XML 91 R108.htm IDEA: XBRL DOCUMENT v2.4.0.6
Share-Based Compensation (Narrative) (Details) (USD $)
12 Months Ended
Dec. 31, 2012
Dec. 31, 2011
Dec. 31, 2010
Dec. 31, 2012
Restricted Stock Units (RSUs) [Member]
Dec. 31, 2011
Restricted Stock Units (RSUs) [Member]
Dec. 31, 2010
Restricted Stock Units (RSUs) [Member]
Dec. 31, 2012
Stock Options [Member]
Dec. 31, 2012
Non-Vested Synovus Shares And Restricted Share Units [Member]
Dec. 31, 2011
Non-Vested Synovus Shares And Restricted Share Units [Member]
Dec. 31, 2010
Non-Vested Synovus Shares And Restricted Share Units [Member]
Dec. 31, 2011
Non-vested Stock [Member]
Dec. 31, 2010
Non-vested Stock [Member]
Dec. 31, 2005
Performance-Vesting Shares [Member]
Dec. 31, 2012
2007 Omnibus Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                            
Shares of authorized but unissued common stock reserved for future grants                           23,855,801 [1]
Vesting period minimum (years)       3 years 2 years                  
Vesting period maximum (years)       3 years 2 years                  
Non-option awards granted       3,330,293 3,815,942 844,205         0 0 63,386  
Non-option awards granted, weighted-average grant-date fair value (per share) $ 2.05     $ 2.07 $ 2.65 $ 2.80         $ 0.00 $ 0.00    
Stock options granted 4,586,666 0 3,442,586                      
Options granted, weighted-average exercise price (per share) $ 2.05 $ 0.00 $ 2.80                      
Share-based compensation expense $ 9,399,000 $ 6,029,000 $ 7,158,000                      
Tax benefit recognized from compensation expense 3,600,000   128,000                      
Unrecognized compensation cost 9,000,000     5,700,000     3,300,000              
Grant-date fair value of options granted $ 1.03   $ 1.50                      
Options outstanding, aggregate intrinsic value 1,800,000                          
Options exercisable, aggregate intrinsic value 31,000                          
Options outstanding, weighted average remaining contractual term (years) 4 years 8 months 9 days                          
Options exercisable, weighted average remaining contractual term (years) 2 years 11 months 12 days                          
Total grant date fair value of stock options vested 2,900,000 1,500,000 2,300,000                      
Unrecognized compensation cost, period of recognition (years)       1 year 5 months 5 days     1 year 6 months 15 days              
Non-option awards vested, total fair value               3,500,000 356,000 5,100,000        
Cash received from exercise of stock options     269,000                      
Salary stock units, granted 770,573                          
Salary stock units 1,900,000                          
Tax deficiency realized from exercise of options $ 715,000 $ 677,000 $ 3,000,000                      
[1] Does not include information for equity compensation plans assumed by Synovus in mergers. A total of 186,438 shares of Common Stock were issuable upon exercise of options granted under plans assumed in mergers and outstanding at December 31, 2012. The weighted average exercise price of all options granted under plans assumed in mergers and outstanding at December 31, 2012 was $7.46. Synovus cannot grant additional awards under these assumed plans.